UK research consortium given £2 million to control monkeypox europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
New COVID-19 drug screening hub established in Scotland
7th January 2021
A new COVID-19 drug screening and resistance facility, funded by medical research charity LifeArc, has been established at the MRC-University of Glasgow Centre for Virus Research (CVR).
The project – COVID-19 Drug-Screening and Resistance Hub (CRUSH) – has been granted £2.5m to establish a hub dedicated to supporting and accelerating COVID-19 antiviral innovation drug translation.
It is funded by £2m from LifeArc plus additional funding from the Medical Research Council, with the hub set to be delivered by the University of Glasgow in Collaboration with LifeArc and the University of Dundee Drug Discovery Unit.